Cardiovascular

Latest News

AJMC
Impact of Delayed Adoption of Novel Atrial Fibrillation Treatments

December 11th 2024

Using direct oral anticoagulants as a case study, the authors examined how delayed adoption of novel treatments could impact patient health outcomes and cost.

Highlights from ASPC Congress 2024 | Image Credit: venngage.com
ICYMI: Highlights From ASPC Congress 2024

December 9th 2024

EKG heartbeat line | Image Credit: Jiva Core - stock.adobe.com
Acoramidis Sustains Benefits in Patients With ATTR-CM in Open-Label Extension Study

December 6th 2024

Atrial fibrillation | Image credit: ibreakstock - stock.adobe.com
Lifestyle Changes Ease AFib Symptoms but Don't Lower Burden vs Standard Care

December 5th 2024

FDA headquarters | Image Credit: Grandbrothers - stock.adobe.com
FDA Approves Acoramidis for ATTR-CM

November 25th 2024

Advancements in Population Health Strategies for Cardiovascular Risk Management

Experts discuss how lipoproteins drive atherosclerotic heart disease, review the different guidelines and recommendations on Lp(a) testing, and insights from clinical trials.

Hands holding a heart with a heartbeat on it and the words AJMC Insights

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo